AI-generated summary
The authors retrospectively reviewed medical records of 68 patients undergoing stem cell transplantation who received prophylactic photobiomodulation at one Brazilian hospital. They report that 54.4% developed oral mucositis, with no grade 3 or 4 cases, and that younger age, certain conditioning regimens, and pharyngeal mucositis were associated with its occurrence.
- Participants
- 68
- Who or what was studied
- Patients undergoing hematopoietic stem cell transplantation receiving prophylactic photobiomodulation at a reference hospital in Brazil
- Limits stated in the abstract
- The retrospective design, single-center setting, and reliance on medical records mean the associations cannot establish cause and effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: GRADE, Photobiomodulation, Oral mucositis, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.